Form 4 for CRL Charles River Laboratories
Accepted 2025-05-29 00:00:00 ET · period of report 2025-05-26 · accession 0001127602-25-015900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-29 | 2025-05-26+ | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $137.17 | -366 | 19.4K | -2% | -$50.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-28 | F | D | 83 | $138.65 | 19,147 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-27 | F | D | 122 | $136.73 | 19,230 | D | — | — | |
| 3 | Common | Common Stock | 2025-05-26 | F | D | 161 | $136.73 | 19,352 | D | — | — |